The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis

BACKGROUND: Until now, there is no effective anti-fibrotic therapy available for liver cirrhosis. Stem cell therapies have been studied for the treatment of hepatic fibrosis. However, the use of embryonic stem cells or induced pluripotent stem cells (iPSC) has limitations such as ethical concern or...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Stem Cell Res Ther
Main Authors: Park, Suhyun, In Hwang, Seon, Kim, Jonghun, Hwang, Seoyeon, Kang, Sohee, Yang, Sera, Kim, Jonghwa, Kang, Wonseok, Kim, Kyun-Hwan, Han, Dong Wook, Paik, Yong-Han
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2019
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6330392/
https://ncbi.nlm.nih.gov/pubmed/30635054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-1127-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares